Jump to content

Pages with the fewest revisions

Showing below up to 50 results in range #251 to #300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Phentermine (2 revisions)
  2. Effect:Autonomous voice communication (2 revisions)
  3. Effect:Dehydration (2 revisions)
  4. Phenotype:CYP3A4 intermediate metabolizer (2 revisions)
  5. Effect:Double vision (2 revisions)
  6. Phenotype:CYP2C19 poor metabolizer (2 revisions)
  7. Meloxicam (2 revisions)
  8. Effect:Color shifting (2 revisions)
  9. Problem:Agoraphobia (2 revisions)
  10. Effect:Optical sliding (2 revisions)
  11. Problem:Hoarding Disorder (2 revisions)
  12. Ivermectin (2 revisions)
  13. Effect:Serious cardiac event (2 revisions)
  14. Problem:Cyclothymic Disorder (2 revisions)
  15. Effect:Peripheral vasculopathy (2 revisions)
  16. Problem:Hangover (2 revisions)
  17. Sodium Chloride (2 revisions)
  18. Effect:Auditory distortion (2 revisions)
  19. Problem:Psoriasis (2 revisions)
  20. Dexamethasone (2 revisions)
  21. Effect:Environmental orbism (2 revisions)
  22. Problem:Dependent Personality Disorder (2 revisions)
  23. Effect:Brightness alteration (2 revisions)
  24. Penicillin G (2 revisions)
  25. Dicyclomine (2 revisions)
  26. Effect:Personality regression (2 revisions)
  27. Problem:Embarrassment (2 revisions)
  28. Telmisartan (2 revisions)
  29. Chlorthalidone (2 revisions)
  30. Effect:Anticholinergic effects (2 revisions)
  31. Problem:Avoidant/Restrictive Food Intake Disorder (2 revisions)
  32. Insulin Degludec (2 revisions)
  33. Effect:Personal bias suppression (2 revisions)
  34. Problem:Alzheimer disease (2 revisions)
  35. Atorvastatin (2 revisions)
  36. Effect:Perception of predeterminism (2 revisions)
  37. Problem:Cardiovascular risk reduction in obesity (2 revisions)
  38. Sucralfate (2 revisions)
  39. Effect:Personal meaning intensification (2 revisions)
  40. Effect:Diarrhea (2 revisions)
  41. Bimatoprost (2 revisions)
  42. Effect:Neuroplasticity (2 revisions)
  43. Effect:Anxiolysis (2 revisions)
  44. Linaclotide (2 revisions)
  45. Effect:External auditory hallucination (2 revisions)
  46. Effect:Photophobia (2 revisions)
  47. Phenotype:NUDT15 normal metabolizer (2 revisions)
  48. Dapagliflozin (2 revisions)
  49. Effect:Color tinting (2 revisions)
  50. Phenotype:CYP2C9 poor metabolizer (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)